BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19199705)

  • 1. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery.
    Yu KH; Barry CG; Austin D; Busch CM; Sangar V; Rustgi AK; Blair IA
    J Proteome Res; 2009 Mar; 8(3):1565-76. PubMed ID: 19199705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.
    Wehr AY; Hwang WT; Blair IA; Yu KH
    J Proteome Res; 2012 Mar; 11(3):1749-58. PubMed ID: 22264027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer.
    Rangiah K; Tippornwong M; Sangar V; Austin D; Tétreault MP; Rustgi AK; Blair IA; Yu KH
    J Proteome Res; 2009 Nov; 8(11):5153-64. PubMed ID: 19769411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry.
    Shah SJ; Yu KH; Sangar V; Parry SI; Blair IA
    J Proteome Res; 2009 May; 8(5):2407-17. PubMed ID: 19271751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
    Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
    Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach.
    Grønborg M; Kristiansen TZ; Iwahori A; Chang R; Reddy R; Sato N; Molina H; Jensen ON; Hruban RH; Goggins MG; Maitra A; Pandey A
    Mol Cell Proteomics; 2006 Jan; 5(1):157-71. PubMed ID: 16215274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.
    Nie S; Yin H; Tan Z; Anderson MA; Ruffin MT; Simeone DM; Lubman DM
    J Proteome Res; 2014 Dec; 13(12):6058-66. PubMed ID: 25393578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.
    Liu X; Zheng W; Wang W; Shen H; Liu L; Lou W; Wang X; Yang P
    Br J Cancer; 2017 Dec; 117(12):1846-1854. PubMed ID: 29123261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.
    Yoneyama T; Ohtsuki S; Honda K; Kobayashi M; Iwasaki M; Uchida Y; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Huang W; Yamada T; Tachikawa M; Terasaki T
    PLoS One; 2016; 11(8):e0161009. PubMed ID: 27579675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
    Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
    Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
    Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
    Xiong Y; Shi C; Zhong F; Liu X; Yang P
    Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.
    Kuo KK; Kuo CJ; Chiu CY; Liang SS; Huang CH; Chi SW; Tsai KB; Chen CY; Hsi E; Cheng KH; Chiou SH
    Pancreas; 2016 Jan; 45(1):71-83. PubMed ID: 26262590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass Spectrometry-Based Proteomics for Biomarker Discovery.
    Cao Z; Yu LR
    Methods Mol Biol; 2022; 2486():3-17. PubMed ID: 35437715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A universal SI-traceable isotope dilution mass spectrometry method for protein quantitation in a matrix by tandem mass tag technology.
    Li J; Wu L; Jin Y; Su P; Yang B; Yang Y
    Anal Bioanal Chem; 2016 May; 408(13):3485-93. PubMed ID: 26942737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
    Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
    Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mining the acidic serum proteome utilizing off-gel isoelectric focusing and label free quantitative liquid chromatography mass spectrometry.
    Smith J; Davey G; Polom K; Roviello F; Bones J
    J Chromatogr A; 2018 Sep; 1566():32-43. PubMed ID: 29945787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.
    Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Datta Gupta S; Bahadur S; Siu KW
    Mol Cell Proteomics; 2008 Jun; 7(6):1162-73. PubMed ID: 18339795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative quantitation of proteins in expressed prostatic secretion with a stable isotope labeled secretome standard.
    Zhao T; Zeng X; Bateman NW; Sun M; Teng PN; Bigbee WL; Dhir R; Nelson JB; Conrads TP; Hood BL
    J Proteome Res; 2012 Feb; 11(2):1089-99. PubMed ID: 22077639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.